SCHEMBL31475656

SCHEMBL31475656

COC(=O)c1cccc(S(N)(=O)=O)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
CYP1A2 P05177 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CA9 Q16790 5/20 0.46
CA5A P35218 1/20 0.46
CA12 O43570 4/20 0.43
CA14 Q9ULX7 2/20 0.43
CA7 P43166 1/20 0.43
ALDH1A1 P00352 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962368 1.00 MAPT (0.47) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL22982390 0.83 CYP1A2 (0.50) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL29459164 0.83 CYP1A2 (0.50) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL31455733 0.82 CYP1A2 (0.49) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL69653 0.80 MAPT (0.64) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL22012729 0.79 ALDH1A1 (0.46) MAPTCYP1A2SMN1; SMN2GAANPC1
SCHEMBL3465738 0.79 PIM1 (0.47) CA1CA2CA9CA12CA14
SCHEMBL480113 0.75 MAPT (0.51) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL29918942 0.75 MAPT (0.51) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL17276045 0.75 MAPT (0.55) MAPTCYP1A2SMN1; SMN2GAARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166065-B Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2025-04-15 CN disclosed